Yan, Xiaocai http://orcid.org/0000-0002-9796-0504
Managlia, Elizabeth
Zhao, You-Yang
Tan, Xiao-Di
De Plaen, Isabelle G. http://orcid.org/0000-0002-1742-2926
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (116568)
Article History
Received: 11 August 2021
Accepted: 11 March 2022
First Online: 6 April 2022
Competing interests
: I.D.P. received a grant from Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, for testing rhIGF-1/BP3 in experimental NEC. X.Y., E.M, Y.Y.Z., and X.D.T. have no competing interests to declare.